Regenxbio RGNX
NASDAQ RGNX
$8.94 -0.26 (-2.83%)
As of: Sep 4, 2026 · 3:59 PM EDT

Regenxbio (RGNX) Property, Plant & Equipment (Net) (QoQ) (2015 - 2025)

Analysis

Regenxbio (RGNX) Property, Plant & Equipment (Net) (QoQ) (2015 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Regenxbio 472.74 Mn 367.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -2.47%
Sep 30, 2025 -3.15%
Jun 30, 2025 -3.04%
Mar 31, 2025 -2.63%
Dec 31, 2024 -2.46%
Sep 30, 2024 -2.76%
Jun 30, 2024 -2.89%
Mar 31, 2024 -3.36%
Dec 31, 2023 -2.53%
Sep 30, 2023 -2.27%
Jun 30, 2023 -2.04%
Mar 31, 2023 -0.08%
Dec 31, 2022 0.55%
Sep 30, 2022 1.51%
Jun 30, 2022 2.63%
Mar 31, 2022 2.83%
Dec 31, 2021 7.62%
Sep 30, 2021 14.57%
Jun 30, 2021 19.41%
Mar 31, 2021 58.22%